Individual Coverage HRAs and the Mid-Market Health Benefit Decision in 2026

For a decade, the serious conversation about controlling health benefit costs for a mid-market employer led in one direction: take on risk. Move off the fully insured plan, self-fund the claims, add stop-loss protection, and — for employers ready to go further — pool that risk with others in a group medical captive. That path is still the right one for many organizations. But in 2026 a different model has grown large enough that no benefits conversation is complete without it. The individual coverage health reimbursement arrangement, or ICHRA, flips the question from how an employer owns its health risk to whether it should own that risk at all.

The growth is no longer theoretical

ICHRA has moved from a niche idea to a measurable shift. According to the HRA Council's Growth Trends report released in August 2026, ICHRA adoption grew 99 percent year over year among the organizations it tracks, with 6,382 new employers adding the benefit. Confirmed participation reached 261,000 employees — roughly 402,000 covered lives including dependents — and industry estimates put the real figure higher, with more than one million covered lives expected by January 2027. The fastest growth is among larger employers: adoption among organizations with 1,000 or more employees rose 178 percent, and the segment with 50 or more employees grew 108 percent. This is no longer a small-group experiment. It is moving up-market into exactly the mid-size and larger employers that would otherwise be self-funding.

How it actually works

The mechanism is a defined-contribution model for health benefits. Instead of sponsoring a group plan and bearing its claims, the employer sets a tax-free monthly allowance. Employees buy their own individual coverage on the open market and are reimbursed up to the allowance. The employer's cost is the contribution it chooses — known, fixed, and budgetable in advance — rather than a claims experience that can swing twenty points in a bad year. For an organization whose leadership values cost predictability above all, that is the entire appeal: the health benefit becomes a line item the employer controls rather than a variable it absorbs.

The trade-off is real, and it runs both ways

A defined-contribution model does not eliminate risk. It transfers it — to the employee, and to the individual market. The employer gains a predictable budget; the employee takes on the task of choosing a plan and the exposure to individual-market rate changes. That makes the stability of the individual market itself a live question. Early analyses of the 2027 individual rate filings matter directly to ICHRA employers, because the value of a fixed allowance depends on what that allowance can actually buy. An allowance that covers a strong plan this year may cover less next year if individual-market rates climb — the very cross-subsidization and rate volatility that self-funding was meant to leave behind, reappearing in a different part of the system.

This is the honest comparison a mid-market employer has to make, and it is not one-size-fits-all. A self-funded plan — particularly one placed in a group medical captive — lets a disciplined employer keep the underwriting margin on its own good claims experience, control plan design, and build reserves over time. It rewards the organization willing to own and manage its risk. ICHRA rewards the organization that would rather convert that risk into a fixed, administrable contribution and let employees transact in the individual market. One is ownership; the other is defined contribution. Neither is universally correct.

The decision deserves the same rigor as the risk it replaces

What ICHRA's rapid growth should not become is a default — a model adopted because it is growing rather than because it fits. The organizations that will regret the move are the ones that treat it as an exit from thinking about health risk rather than a different way of structuring it. Workforce demographics, the geographic spread of employees, the strength of the local individual market, the appetite for employee disruption, and the long-run cost trajectory all bear on whether defined contribution or risk ownership serves the organization better. Congress is weighing legislation to codify ICHRA into statute, which would further stabilize the model — another reason to evaluate it deliberately now rather than react to it later.

This is precisely the analysis PFTN's four-step process is built for. Strategic Discovery surfaces what the organization actually wants from its health benefit — predictability, control, cost ownership, or some balance of the three. Risk Assessment models the real cost and risk of each path, self-funded captive and ICHRA alike, against the organization's own workforce and market. Solution Design structures the chosen model — or a combination — so the decision rests on the organization's numbers rather than on whichever option is in fashion. Ongoing Optimization revisits it as the individual market, the regulatory picture, and the workforce evolve.

The mid-market health benefit decision has always been a question of who should carry the risk. ICHRA does not answer that question. It widens it — and widening it is reason to decide with discipline, not drift.

— Ryan Mefford, President & Risk Advisor